StonvexLoading…
StonvexStonvexStonvexCore line items from SW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $8.16B | $7.71B | $31.18B | $23.60B | $15.60B |
Operating Income | Not available | $253.00M | $1.72B | $1.33B | $804.00M |
Net Income | Not available | $65.00M | $699.00M | $602.00M | $356.00M |
EPS (Diluted) | $0.48 | $0.12 | $1.33 | $1.14 | $0.68 |
Total Assets | Not available | $45.17B | $45.16B | $45.57B | $45.75B |
Total Liabilities | Not available | $27.09B | $26.80B | $27.11B | $27.42B |
Cash & Equivalents | Not available | $674.00M | $892.00M | $851.00M | $778.00M |
Free Cash Flow OCF − CapEx | Not available | $-420.00M | $1.20B | $588.00M | $65.00M |
Shares Outstanding | Not available | 524.46M | 522.31M | 522.17M | 522.06M |